PHESGO® is a subcutaneous combination of pertuzumab and trastuzumab for HER2-positive breast cancer, designed to reduce treatment time.
Related products
Wegovy 1.7mg/0.7ml Inj. x 1Pen
Semaglutide Injection
Product not listed ? Send us a DM !  > Dismiss
PHESGO® is a subcutaneous combination of pertuzumab and trastuzumab for HER2-positive breast cancer, designed to reduce treatment time.